Citations

Clear

846 citation(s) found for "Li, Min".

Abstract LB-348: Integrated analysis of microRNA and mRNA expression in microsatellite-stable colon cancer using next-generation sequencing and cDNA microarrays
Loo, Lenora W. M. , Casey, Graham , Gallinger, Steven , Thibodeau, Stephen N. , Tiirikainen, Maarit , Song, Min‐Ae , Cheng, Iona C. , Marchand, Loı̈c Le

Mayo Clinic

Cancer Research | July 21, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: LB-348-LB-348

10.1158/1538-7445.am2011-lb-348 Get It

Abstract Alterations in the expression of microRNAs (miRNAs) contribute to the development and progression of colon cancer, which arises from the accumulation of genetic and epigenetic alterations in the colon tissue. With the advent of next-generation sequencing (NGS), new depths can be reached, allowing for comprehensive profiling of known and novel miRNAs. To profile the miRNAs and their associated target genes in colon cancer, we examined differential expression of miRNAs and predicted target genes between tumor and normal tissue of microsatellite stable (MSS) and CpG island methylator phenotype (CIMP)-negative colon cancer. Ten fresh-frozen colon tumors and 10 adjacent normal mucosa were profiled for miRNAs using the SOLiD NGS platform and mRNA expression analysis was conducted using Affymetrix arrays. To identify differentially expressed miRNAs in tumor versus normal tissue, analysis of variance was conducted that included Bonferroni correction. Integrated expression analysis of miRNAs and their target mRNAs was conducted using Pearson's correlation and the Benjamini and Hochberg's false discovery rate. Both analyses were done using Partek Genomics Suite software. Nineteen miRNAs were significantly differentially expressed in tumor versus normal tissue (fold change ≥ ±2 and p<0.05). Six of these 19 miRNAs have previously been associated with colon cancer (miR-30a, miR-31, miR-135b, miR-182, miR-183 and miR-202). Integrated analysis of miRNA and predicted target mRNA expression yielded 97 significantly correlated miRNA::mRNA pairs for 14 miRNAs with 92 genes (absolute r = 0.71–0.88, q<0.05). Within these miRNA::mRNA pairs, expression levels of the 6 colon cancer-associated miRNAs were correlated with 33 target genes and 8 miRNAs newly identified to be differentially expressed in colon cancer were correlated with 57 target genes. The top functional Ingenuity Pathway Analysis gene ontology categories (p<0.05) for the 92 genes were gastrointestinal disease (18 genes), genetic disorder (21genes), inflammatory disease (15 genes) and cancer (21 genes). The correlated target genes included several genes implicated in colon cancer such as CDH3, NKD1, RGS2, TCFL5 and ZEB2. In summary, deep miRNA sequencing among MSS/CIMP-negative colon tumors confirmed differential expression of 6 colon cancer-associated miRNAs and identified 13 miRNAs not previously reported in colon cancer. Differential expression of most of the discovered miRNAs was correlated with the expression of genes potentially relevant for colon cancer. If confirmed, these miRNAs may serve as new biomarkers for colon cancer and may further our understanding of the epigenetic changes and pathways involved in the development of colon cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-348. doi:10.1158/1538-7445.AM2011-LB-348
Abstract B20: GLI1 overexpression contributes to HCC recurrence partly through the induction of SNAI1-induced epithelial-to-mesenchymal transition
Gai, Xiaohong, Fernández-Zapico, Martín E. , Roberts, Lewis R. , Moser, Catherine D., Nakamura, Ikuo , Shire, Abdirashid M., Yang, Judong, Almada, Luciana L. , Thorgeirsson, Snorri S., Zheng, Xin Min , Hu, Chunling , Elsawa, Sherine F. , Roberts, Lewis R

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 18_Supplement | Pages: B20-B20

10.1158/1538-7445.fbcr11-b20 Get It

Abstract Background/Aim: Glioma-associated oncogene 1 (GLI1) is one of the most important transcription factors in the hedgehog (Hh) signaling pathway and has been shown to be involved in embryonic development and tumor progression. The epithelial-to-mesenchymal transition (EMT) is an important cellular program which contributes to invasion and metastasis of cancer. We have previously shown that GLI1 may promote HCC metastasis via EMT. Here, we demonstrate that GLI1 upregulates SNAI1 expression, induces EMT, and promotes HCC recurrence in vivo and in vitro. Methods: Gli1 mRNA was assessed in 139 HCCs by microarray and its correlation with HCC recurrence and SNAI1 mRNA expression was analyzed. In vitro, the mRNA and protein expression of GLI1 was measured in Gli1-negative Huh7 cells transfected with GU1 and GU1-expressing SNU398 cells transfected with antisense oligonucleotides targeting GU1 (GLI1 ASO). GLI1-dependent transcriptional activity was assessed with GU reporter luciferase assay and electrophoretic mobility shift assay (EMSA). The interaction between Gli1, SNAI1 and EMT was assessed by real-time PCR, Western immunoblotting and immunofluorescence. Effects of GLI1 on proliferation, viability, migration, and invasion of tumor cells were also assessed. Results: GLI1 mRNA was detected in 74 HCC tumors and found to be upregulated in 43 (58.1 %) HCCs. Increased Gli1 mRNA in HCCs was associated with tumor recurrence after resection. There was a positive correlation between GLI1 and SNAI1 mRNA expression. In HCC cells, GLI1 overexpression increased Gli1-dependent transcriptional activity, proliferation, viability, migration, and invasion of tumor cells. GU1 also increased SNAI1 expression and induced the EMT. Opposite effects were observed in GU1-knockdown models. Conclusion: Together, these findings identify a novel mechanism mediating HCC recurrence that includes GLI1-mediated activation of EMT via upregulation of SNAI1. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the Second AACR International Conference on Frontiers in Basic Cancer Research; 2011 Sep 14-18; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2011;71(18 Suppl):Abstract nr B20.
Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy
Suárez, Guillermo A. , Chalk, Colin , Russell, James W. , O’Brien, Peter C. , Dyck, Peter James , Kim, Seung Min

Mayo Clinic

Neurology | May 13, 2012 | Volume: 57 | Issue: 6 | Pages: 1118-1120

10.1212/wnl.57.6.1118 | PMID 11571349 Get It

Euryhaline pufferfish NBCe1 differs from nonmarine species NBCe1 physiology
Chang, Min‐Hwang , Plata, Consuelo , Kurita, Yukihiro, Kato, Akira , Hirose, Shigehisa , Romero, Michael F. , Romero, Michael F , Kato, Akira

Mayo Clinic

American Journal of Physiology-Cell Physiology | December 8, 2011 | Volume: 302 | Issue: 8 | Pages: C1083-C1095

10.1152/ajpcell.00233.2011 | PMID 22159080 Get It

Marine fish drink seawater and eliminate excess salt by active salt transport across gill and gut epithelia. Euryhaline pufferfish ( Takifugu obscurus , mefugu) forms a CaCO3 precipitate on the luminal gut surface after transitioning to seawater. NBCe1 (Slc4a4) at the basolateral membrane of intestinal epithelial cell plays a major role in transepithelial intestinal HCO3− secretion and is critical for mefugu acclimation to seawater. We assayed fugu-NBCe1 (fNBCe1) activity in the Xenopus oocyte expression system. Similar to NBCe1 found in other species, fNBCe1 is an electrogenic Na+/HCO3− cotransporter and sensitive to the stilbene inhibitor DIDS. However, our experiments revealed several unique and distinguishable fNBCe1 transport characteristics not found in mammalian or other teleost NBCe1-orthologs: electrogenic Li+/ nHCO3− cotransport; HCO3− independent, DIDS-insensitive transport; and increased basal intracellular Na+ accumulation. fNBCe1 is a voltage-dependent Na+/ nHCO3− cotransporter that rectifies, independently from the extracellular Na+ or HCO3− concentration, around −60 mV. Na+ removal (0Na+ prepulse) is necessary to produce the true HCO3−-elicited current. HCO3− addition results in huge outward currents with quick current decay. Kinetic analysis of HCO3− currents reveals that fNBCe1 has a much higher transport capacity (higher maximum current) and lower affinity (higher Km) than human kidney NBCe1 (hkNBCe1) does in the physiological range (membrane potential = −80 mV; [HCO3−] = 10 mM). In this state, fNBCe1 is in favor of operating as transepithelial HCO3− secretion, opposite of hkNBCe1, from blood to the luminal side. Thus, fugu-NBCe1 represents the first ortholog-based tool to study amino acid substitutions in NBCe1 and how those change ion and voltage dependence.
Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibit
Desmoulin, Sita Kugel, Cherian, Christina, Polin, Lisa , White, Kathryn, Kushner, Juiwanna , Fulterer, Andreas, Chang, Min‐Hwang , Mitchell-Ryan, Shermaine , Stout, Mark, Romero, Michael F. , Hou, Zhanjun , Gangjee, Aleem , Wang, Lei , Matherly, Larry H. , Romero, Michael F

Mayo Clinic

Journal of Medicinal Chemistry | August 31, 2011 | Volume: 54 | Issue: 20 | Pages: 7150-7164

10.1021/jm200739e | PMID 21879757 Get It

Assessment of Renal Lesions With Blood Oxygenation Level–Dependent MRI at 3 T: Preliminary Experience
Kim, Chan Kyo , Park, Byung Kwan , Kim, EunJu, Min, Ji Hye , Kim, Bohyun

Mayo Clinic

American Journal of Roentgenology | August 23, 2011 | Volume: 197 | Issue: 3 | Pages: W489-W494

10.2214/ajr.10.6319 | PMID 21862777 Get It

ATP-Sensitive Potassium (KATP) Channel Activation Decreases Intraocular Pressure in the Anterior Chamber of the Eye
Chowdhury, Uttio Roy, Bahler, Cindy K., Hann, Cheryl R., Chang, Min‐Hwang , Resch, Zachary T., Romero, Michael F. , Fautsch, Michael P. , Romero, Michael F

Mayo Clinic

Investigative Opthalmology & Visual Science | July 9, 2011 | Volume: 52 | Issue: 9 | Pages: 6435

10.1167/iovs.11-7523 | PMID 21743021 Get It

Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
Leon, Johanny Tonos De, Iwai, Aki, Féau, Clémentine, Garcia, Yenni A., Balsiger, Heather A., Storer, Cheryl L., Suro, Raquel M., Garza, Kristine M. , Kim, Yeong Sang, Chen, Yu , Ning, Yang‐Min, Fletterick, Robert J. , Guy, R. Kiplin , Trepel, Jane B. , Neckers, Leonard Μ. , Cox, Marc B. , Lee, Sunmin , Riggs, Daniel L.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 5, 2011 | Volume: 108 | Issue: 29 | Pages: 11878-11883

10.1073/pnas.1105160108 | PMID 21730179 Get It

Drugs that target novel surfaces on the androgen receptor (AR) and/or novel AR regulatory mechanisms are promising alternatives for the treatment of castrate-resistant prostate cancer. The 52 kDa FK506 binding protein (FKBP52) is an important positive regulator of AR in cellular and whole animal models and represents an attractive target for the treatment of prostate cancer. We used a modified receptor-mediated reporter assay in yeast to screen a diversified natural compound library for inhibitors of FKBP52-enhanced AR function. The lead compound, termed MJC13, inhibits AR function by preventing hormone-dependent dissociation of the Hsp90-FKBP52-AR complex, which results in less hormone-bound receptor in the nucleus. Assays in early and late stage human prostate cancer cells demonstrated that MJC13 inhibits AR-dependent gene expression and androgen-stimulated prostate cancer cell proliferation.
Abstract PD06-08: Size Matters: Incorporation of Sentinel Lymph Node (SLN) Metastasis Size into a Nomogram Predicting NonSLN Involvement in SLN Positive Breast Cancer Patients
Mittendorf, EA , Boughey, JC , Degnim, AC, Harrell, Robyn K., Yi, Min , Ross, MI, Babiera, GV, Kuerer, HM, Bedrosian, I., Hunt, KK , Hwang, RF, Bassett, Roland L. , Meric‐Bernstam, Funda , Kuerer, Henry Mark, Lucci, Anthony

Mayo Clinic

Cancer Research | April 27, 2011 | Volume: 70 | Issue: 24_Supplement | Pages: PD06-08-PD06-08

10.1158/0008-5472.sabcs10-pd06-08 Get It

Abstract Purpose: Emerging data from cooperative group trials suggests that not all patients with a positive SLN require completion axillary lymph node dissection (ALND). The controversy regarding who will benefit from additional nodal clearance continues, suggesting a need for improved tools to predict non-SLN involvement. We hypothesized that the size of a SLN metastasis evaluated as a continuous variable would be an important predictor of non-SLN involvement. The goal of this study was to determine clinicopathologic factors including SLN metastasis size that predicted non-SLN involvement and to use these factors to construct an improved predictive nomogram. Methods: Using a prospective database, we identified 509 patients with invasive breast cancer from 1996 - 2007 with a positive SLN who underwent ALND. Patients receiving neoadjuvant therapy were excluded. Clinicopathologic data including age, primary tumor size, presence of multifocal disease, histology (invasive ductal vs. invasive lobular vs. mixed invasive), tumor grade, estrogen receptor, progesterone receptor, and HER2/neu status, presence of lymphovascular invasion (LVI), the number of SLNs identified, number of positive SLNs, the maximum SLN metastasis size and the presence of extranodal extension were recorded. For SLNs described only as containing isolated tumor cells, size was recorded as 0.1 mm. Univariate and multivariate logistic regression analyses were performed to identify factors predictive of positive non-SLNs. Using these variables, a nomogram was constructed and subsequently validated using an external cohort of 464 patients. Results: On univariate analysis, the following factors were predictive of positive non-SLNs: number of SLN identified (p<.001), number of positive SLN (p<.001), maximum SLN metastasis size (p<.001), extranodal extension (p<.001), primary tumor size (p=.001), LVI (p=.019) and histology (p=.034). On multivariate analysis, all factors remained significant at the 5% level except LVI. A nomogram was created using these variables. When applied to an external cohort, the nomogram was accurate and discriminating with an area under the receiver operating characteristic curve of .73 (95% CI: .68 - .77). Conclusions: SLN metastasis size is predictive for identifying additional disease in the axilla. These data have been incorporated into a nomogram that accurately predicts the likelihood of having additional, non-SLN metastasis suggesting that routine reporting of the SLN metastasis size would assist with clinical decision making regarding the need to perform a completion ALND. Figures available in online version. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr PD06-08.
Deep Brain Stimulation: Technology at the Cutting Edge
Shah, Rahul S. , Chang, Su-Youne , Min, Hoon‐Ki , Cho, Zang‐Hee , Blaha, Charles D. , Lee, Kendall H. , Min, Hoon-Ki Paul , Blaha, Charles

Mayo Clinic

Journal of Clinical Neurology | January 20, 2011 | Volume: 6 | Issue: 4 | Pages: 167

10.3988/jcn.2010.6.4.167 | PMID 21264197 Get It